Funds and ETFs Teleflex Incorporated

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
209.1 USD +1.18% Intraday chart for Teleflex Incorporated +1.32% -16.15%

ETFs positioned on Teleflex Incorporated

Name Weight AuM 1st Jan change Investor Rating
1.03% 14 M€ -5.07%
0.73% 8 M€ -.--%
0.63% 2 M€ -.--%
0.44% 17 M€ +6.09% -
0.15% 9 M€ -.--% -
0.13% 1 M€ +11.94% -
0.13% 13 M€ -.--% -
0.13% 3 M€ +7.32% -
0.11% 5 M€ -72.95% -
0.08% 2,383 M€ +13.18%
0.06% 219 M€ +17.17% -
0.06% 1,448 M€ -.--% -
0.06% 276 M€ +11.40% -
0.05% 264 M€ -.--% -
0.05% 187 M€ +9.30% -
0.05% 477 M€ +11.68%
0.05% 330 M€ -.--%
0.05% 85 M€ +13.83% -
0.05% 2 M€ +14.69% -
0.04% 744 M€ +8.16%
0.04% 8 M€ +5.45% -
0.04% 7 M€ +5.60% -
0.04% 32 M€ +1.01% -
0.04% 17 M€ +5.27% -
0.04% 2,517 M€ +11.95% -
0.04% 6 M€ +17.98% -
0.04% 121 M€ +7.93% -
0.04% 1,848 M€ +18.39% -
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
209.1 USD
Average target price
245.2 USD
Spread / Average Target
+17.30%
Consensus
  1. Stock Market
  2. Equities
  3. TFX Stock
  4. Funds and ETFs Teleflex Incorporated